These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38984727)

  • 1. Ferrocenyl Azoles: Versatile N-Containing Heterocycles and their Anticancer Activities.
    Sadanala BD; Trivedi R
    Chem Rec; 2024 Jul; 24(7):e202300347. PubMed ID: 38984727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Ferrocene Compounds as Selective Cyclooxygenase (COX-2) Inhibitors: Design, Synthesis, Cytotoxicity and Enzyme-inhibitory Activity.
    Farzaneh S; Zeinalzadeh E; Daraei B; Shahhosseini S; Zarghi A
    Anticancer Agents Med Chem; 2018; 18(2):295-301. PubMed ID: 28971779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferrocene-Based Compounds with Antimalaria/Anticancer Activity.
    Peter S; Aderibigbe BA
    Molecules; 2019 Oct; 24(19):. PubMed ID: 31591298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferrocenyl and organic novobiocin derivatives: Synthesis and their in vitro biological activity.
    Mbaba M; Mabhula AN; Boel N; Edkins AL; Isaacs M; Hoppe HC; Khanye SD
    J Inorg Biochem; 2017 Jul; 172():88-93. PubMed ID: 28441548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of ferrocenyl phosphines as potent antimalarials targeting the digestive vacuole function of Plasmodium falciparum.
    Subramanian G; Sadeer A; Mukherjee K; Kojima T; Tripathi P; Naidu R; Tay SW; Pang JH; Pullarkat SA; Chandramohanadas R
    Dalton Trans; 2019 Jan; 48(3):1108-1117. PubMed ID: 30605200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of biological properties of ferrocenyl-podophyllotoxin conjugates.
    Wieczorek A; Błauż A; Makal A; Rychlik B; Plażuk D
    Dalton Trans; 2017 Aug; 46(33):10847-10858. PubMed ID: 28752867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of a Newly Synthesized Ferrocene Derivative against MCF-7 Breast Cancer Cells and Spheroid Stem Cells through ROS Production and Inhibition of JAK2/STAT3 Signaling Pathway.
    Nourbakhsh M; Farzaneh S; Taghikhani A; Zarghi A; Noori S
    Anticancer Agents Med Chem; 2020; 20(7):875-886. PubMed ID: 31893999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Has Ferrocene Really Delivered Its Role in Accentuating the Bioactivity of Organic Scaffolds?
    Sharma B; Kumar V
    J Med Chem; 2021 Dec; 64(23):16865-16921. PubMed ID: 34792350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Antiproliferative Activity of Ferrocene Derivatives against Drug- Resistant Cancer Cell Lines: A Mini Review.
    Li L; Ma L; Sun J
    Curr Top Med Chem; 2021; 21(19):1756-1772. PubMed ID: 34323188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, docking, machine learning and antiproliferative activity of the 6-ferrocene/heterocycle-2-aminopyrimidine and 5-ferrocene-1H-Pyrazole derivatives obtained by microwave-assisted Atwal reaction as potential anticancer agents.
    Filho EV; Pina JWS; Antoniazi MK; Loureiro LB; Ribeiro MA; Pinheiro CB; Guimarães CJ; de Oliveira FCE; Pessoa C; Taranto AG; Greco SJ
    Bioorg Med Chem Lett; 2021 Sep; 48():128240. PubMed ID: 34217828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferrocene-appended pharmacophores: an exciting approach for modulating the biological potential of organic scaffolds.
    Singh A; Lumb I; Mehra V; Kumar V
    Dalton Trans; 2019 Feb; 48(9):2840-2860. PubMed ID: 30663743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the antitumor activity of a cyclopalladated ferrocene compound assisted by a dual-targeting drug delivery system.
    Gong G; Cao Y; Qian H; Zhou Y; Zhao H; Li L; Wang F; Zhao G
    Chem Commun (Camb); 2018 Jul; 54(60):8312-8315. PubMed ID: 29868665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current development of pyrazole-azole hybrids with anticancer potential.
    Zhang S; Ye Y; Zhang Q; Luo Y; Wang ZC; Wu YZ; Zhang XP; Yi C
    Future Med Chem; 2023 Aug; 15(16):1527-1548. PubMed ID: 37610862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferrocene-containing hybrids as potential anticancer agents: Current developments, mechanisms of action and structure-activity relationships.
    Wang R; Chen H; Yan W; Zheng M; Zhang T; Zhang Y
    Eur J Med Chem; 2020 Mar; 190():112109. PubMed ID: 32032851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colchicine metallocenyl bioconjugates showing high antiproliferative activities against cancer cell lines.
    Kowalczyk K; Błauż A; Ciszewski WM; Wieczorek A; Rychlik B; Plażuk D
    Dalton Trans; 2017 Dec; 46(48):17041-17052. PubMed ID: 29185574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphiphilic conjugates of ferrocene with amino acids and peptides: Design, synthesis, and studies on their aggregation behavior.
    Gurunarayanan V; Ramapanicker R
    J Pept Sci; 2021 Aug; 27(8):e3332. PubMed ID: 33884698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formylation of a metathesis-derived
    Mazur M; Mrozowicz M; Buchowicz W; Koszytkowska-Stawińska M; Kamiński R; Ochal Z; Wińska P; Bretner M
    Dalton Trans; 2020 Aug; 49(33):11504-11511. PubMed ID: 32627790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of heterocyclic azoles derivatives containing pyrazine moiety as potential telomerase inhibitors.
    Zhang YB; Wang XL; Liu W; Yang YS; Tang JF; Zhu HL
    Bioorg Med Chem; 2012 Nov; 20(21):6356-65. PubMed ID: 23018096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azole derivatives as histamine H3 receptor antagonists, part 2: C-C and C-S coupled heterocycles.
    Walter M; Isensee K; Kottke T; Ligneau X; Camelin JC; Schwartz JC; Stark H
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5883-6. PubMed ID: 20727744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of heterobimetallic gold(i) ferrocenyl-substituted 1,2,3-triazol-5-ylidene complexes as potential anticancer agents.
    Aucamp D; Kumar SV; Liles DC; Fernandes MA; Harmse L; Bezuidenhout DI
    Dalton Trans; 2018 Nov; 47(45):16072-16081. PubMed ID: 30276400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.